Emma Scott

3.5k total citations · 2 hit papers
33 papers, 1.4k citations indexed

About

Emma Scott is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Emma Scott has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Hematology and 6 papers in Oncology. Recurrent topics in Emma Scott's work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (8 papers) and Cancer Genomics and Diagnostics (4 papers). Emma Scott is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (8 papers) and Cancer Genomics and Diagnostics (4 papers). Emma Scott collaborates with scholars based in United States, United Kingdom and Belgium. Emma Scott's co-authors include Scott E. Devine, Khalid Mezzi, Nina Shah, Ajai Chari, Saad Z. Usmani, Eugene J. Gardner, Nelson T. Chuang, Kim De Paepe, Tom Van de Wiele and Ashiq Masood and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Emma Scott

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches

2020 304 citations Nina Shah, Ajai Chari et al. Leukemia profile →
Trends in the approval of cancer therapies by the FDA in the twenty-first century

2023 155 citations Emma Scott, Andrea Baines et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Scott United States	13	754	396	351	313	187	33	1.4k
Qing Sang China	16	475 0.6×	206 0.5×	95 0.3×	319 1.0×	74 0.4×	51	1.2k
Eigil Kjeldsen Denmark	27	1.7k 2.3×	670 1.7×	860 2.5×	183 0.6×	261 1.4×	99	2.6k
Sean G. Buchanan United States	20	1.0k 1.4×	605 1.5×	134 0.4×	51 0.2×	118 0.6×	47	1.8k
Liang Zhou China	21	737 1.0×	214 0.5×	147 0.4×	72 0.2×	85 0.5×	79	1.2k
Benigno C. Valdez United States	26	1.7k 2.2×	388 1.0×	295 0.8×	73 0.2×	310 1.7×	94	2.3k
Richard D. Leavitt United States	14	1.1k 1.4×	279 0.7×	954 2.7×	136 0.4×	93 0.5×	25	2.0k
Pui-Kwong Chan United States	14	1.0k 1.4×	318 0.8×	132 0.4×	67 0.2×	138 0.7×	20	1.3k
Jeremy A. Ross United States	22	1.2k 1.6×	622 1.6×	871 2.5×	41 0.1×	72 0.4×	91	2.0k
John F. DeCoteau Canada	24	903 1.2×	401 1.0×	168 0.5×	30 0.1×	139 0.7×	63	1.5k
Luís Lombardía Spain	19	1.0k 1.3×	248 0.6×	113 0.3×	75 0.2×	73 0.4×	31	1.7k

Countries citing papers authored by Emma Scott

Since Specialization

Citations

This map shows the geographic impact of Emma Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Scott more than expected).

Fields of papers citing papers by Emma Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Scott. The network helps show where Emma Scott may publish in the future.

Co-authorship network of co-authors of Emma Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Scott. A scholar is included among the top collaborators of Emma Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Scott. Emma Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johannesen, Katrine M., John Gásdal Karstensen, Emma Scott, et al.. (2025). A Novel Case of Biallelic MLH3 Variants in a Patient With Rectal Cancer and Polyps. Clinical Genetics. 107(4). 480–482. 3 indexed citations

Scott, Emma, Andrea Baines, Yutao Gong, et al.. (2023). Trends in the approval of cancer therapies by the FDA in the twenty-first century. Nature Reviews Drug Discovery. 22(8). 625–640. 155 indexed citations breakdown →

Bashir, Qaiser, Taiga Nishihori, Marcelo C. Pasquini, et al.. (2022). A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial. Transplantation and Cellular Therapy. 29(6). 358.e1–358.e7. 5 indexed citations

Agrawal, Sundeep, Shaily Arora, Laleh Amiri‐Kordestani, et al.. (2022). Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021. JAMA Oncology. 9(2). 266–266. 43 indexed citations

Hultcrantz, Malin, David Kleinman, Astrid McKeown, et al.. (2022). Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14.. Journal of Clinical Oncology. 40(16_suppl). TPS8073–TPS8073. 6 indexed citations

Marchesi, Julian R., et al.. (2022). An observational investigation of the faecal microbiota and metabonome of gastrostomy fed children, on blended and formula diets. Gut Microbes. 14(1). 2138661–2138661. 4 indexed citations

Scott, Emma, Yutao Gong, Ashim Subedee, et al.. (2020). Emerging oncology drug targets in the 21st century: An FDA analysis.. Journal of Clinical Oncology. 38(15_suppl). e14067–e14067.

Shah, Nina, Ajai Chari, Emma Scott, Khalid Mezzi, & Saad Z. Usmani. (2020). B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia. 34(4). 985–1005. 304 indexed citations breakdown →

Cohen, Adam D., Noopur Raje, Jessica Fowler, et al.. (2019). How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma. Clinical Cancer Research. 26(7). 1541–1554. 82 indexed citations

10.

Gardner, Eugene J., Vincent Kwok Lim Lam, Daniel Harris, et al.. (2017). The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Research. 27(11). 1916–1929. 205 indexed citations

11.

Scott, Emma & Scott E. Devine. (2017). The Role of Somatic L1 Retrotransposition in Human Cancers. Viruses. 9(6). 131–131. 60 indexed citations

12.

Scott, Emma, Eugene J. Gardner, Ashiq Masood, et al.. (2016). A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Research. 26(6). 745–755. 183 indexed citations

13.

Liu, Selina Qiuying, Monika A. Davare, Stephen E. Spurgeon, et al.. (2015). Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma. Oncotarget. 6(22). 18921–18932. 42 indexed citations

14.

Sondhi, Dolan, Emma Scott, Alvin Chen, et al.. (2013). Partial Correction of the CNS Lysosomal Storage Defect in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis by Neonatal CNS Administration of an Adeno-Associated Virus Serotype rh.10 Vector Expressing the Human CLN3 Gene. Human Gene Therapy. 25(3). 223–239. 31 indexed citations

15.

Scott, Emma, Alexander E. Perl, Selina M. Luger, Martin Carroll, & Margaret Kasner. (2011). A Feasibility Study of Rapamycin with Hyper-CVAD Chemotherapy in Adults with Acute Lymphoblastic Leukemia (ALL) and Other Aggressive Lymphoid Malignancies and Evaluation of mTOR Signaling Using Phosphoflow. Blood. 118(21). 4245–4245. 1 indexed citations

16.

Scott, Emma & Donna Reece. (2011). What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?. Hematology. 2011(1). 205–207. 1 indexed citations

17.

Scott, Emma, Elizabeth O. Hexner, Alexander E. Perl, & Martin Carroll. (2010). Targeted Signal Transduction Therapies in Myeloid Malignancies. Current Oncology Reports. 12(6). 358–365. 7 indexed citations

18.

Scott, Emma, et al.. (2010). Risk Factors for Venous Thromboembolism In Hospitalized Cancer Patients with Central Catheters. Blood. 116(21). 810–810. 1 indexed citations

19.

Scott, Emma & Donald L. Elbert. (2007). Mass spectrometric mapping of fibrinogen conformations at poly(ethylene terephthalate) interfaces. Biomaterials. 28(27). 3904–3917. 14 indexed citations

20.

Scott, Emma, et al.. (2006). Complete Androgen Insensitivity Syndrome in A Black South African Family: A Clinical and Molecular Investigation. Endocrine Practice. 12(6). 664–669. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact